Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome

Diseases of the Colon and Rectum

Volumn 52, Issue 12, 2009, Pages 1949-1955

  Jarrar, Awad W ^a   Church, James M ^a   Fay, Susan ^a   Kalady, Matthew F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Familial colorectal cancer; Hereditary nonpolyposis colorectal cancer; Hyperplastic polyposis; Serrated polyps

Indexed keywords

ADULT; AGED; AMSTERDAM CRITERIA; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COLON POLYPOSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILIAL POLYPOSIS; FAMILY HISTORY; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; HYPERPLASTIC POLYPOSIS SYNDROME; LUNG CANCER; MALE; PHENOTYPE; PROSTATE CANCER; RISK FACTOR; SALIVARY GLAND CANCER; TESTIS CANCER; COLORECTAL TUMOR; GASTROINTESTINAL POLYPOSIS; GENETICS; HYPERPLASIA; MIDDLE AGED; PATHOLOGY; SYNDROME;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; HUMANS; HYPERPLASIA; INTESTINAL POLYPOSIS; MALE; MIDDLE AGED; PHENOTYPE; SYNDROME;

EID: 73949155506     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181b5450c     Document Type: Article

References (34)

1. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on HNPCC. Anticancer Res 1994;14: 1661-1664
2. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453-1456
3. Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006;12: 4943-4950
4. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-685 (Pubitemid 23051366)
5. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002;50:228-234
6. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293: 1979-1985
7. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007;36:947-68, viii.
8. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: Phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 2006;131:30-39
9. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177-184
10. Rubio CA, Stemme S, Jaramillo E, Lindblom A. Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy 2006;38:266-270
11. Burt R, Jass JR. Hyperplastic polyposis. In: Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000.
12. Jass JR. Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract 2008;204:431-447
13. Young J, Barker MA, Simms LA, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005;3:254-263
14. Walsh MD, Buchanan DD, Walters R, et al. Analysis of families with lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis. Fam Cancer, doi:10.1007/s10689-009-9238-8.
15. Soravia C, van der Klift H, Brundler MA, et al. Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum. Am J Med Genet A 2003;121A:159-162
16. Sparr JA, Bandipalliam P, Redston MS, Syngal S. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol 2009;33:309-312
17. Watson P, Vasen HF, Mecklin JP, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008;123:444-449
18. Rosty C, Briere J, Cellier C, et al. Association of a duodenal follicular lymphoma and hereditary nonpolyposis colorectal cancer. Mod Pathol 2000;13:586-590
19. Tomizawa Y, Adachi J, Kohno T, Yamaguchi N, Saito R, Yokota J. Identification and characterization of families with aggregation of lung cancer. Jpn J Clin Oncol 1998;28:192-195
20. Frazier ML, Xi L, Zong J, et al. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer. Cancer Res 2003;63:4805-4808
21. Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2006;55:1467-1474
22. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L, Lindblom A. Somatic BRAF-V600E mutations in familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2270-2273
23. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology 2005;47:32-40.
24. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-1407
25. Andersen SH, Lykke E, Folker MB, Bernstein I, Holck S. Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families. Fam Cancer 2008;7:157-162
26. Rijcken FE, van der Sluis T, Hollema H, Kleibeuker JH. Hyperplastic polyps in hereditary nonpolyposis colorectal cancer. Am J Gastroenterol 2003;98:2306-2311 (Pubitemid 37305375)
27. Rashid A, Houlihan PS, Booker S, Petersen GM, Giardiello FM, Hamilton SR. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000;119:323-332
28. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum 2004;47:2101-2104
29. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 1996;179:20-25
30. Lage P, Cravo M, Sousa R, et al. Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol 2004;99:1779-1784
31. Azimuddin K, Stasik JJ, Khubchandani IT, Rosen L, Riether RD, Scarlatto M. Hyperplastic polyps: "more than meets the eye"? report of sixteen cases. Dis Colon Rectum 2000;43:1309-1313
32. Bengoechea O, Martinez-Penuela JM, Larrinaga B, Valerdi J, Borda F. Hyperplastic polyposis of the colorectum and adenocarcinoma in a 24-year-old man. Am J Surg Pathol 1987;11: 323-327
33. Yeoman A, Young J, Arnold J, Jass J, Parry S. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry.NZ Med J 2007;120:U2827.
34. Young J, Jenkins M, Parry S, et al. Serrated pathway colorectal cancer in the population: genetic consideration. Gut 2007;56: 1453-1459